LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 31 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,086,709 | +1.8% | 3,117,000 | 0.0% | 0.19% | +101.0% |
| Q4 2022 | $3,033,231 | +0.6% | 3,117,000 | 0.0% | 0.10% | +31.5% |
| Q3 2022 | $3,016,000 | +1.0% | 3,117,000 | 0.0% | 0.07% | +5.8% |
| Q2 2022 | $2,985,000 | +162.5% | 3,117,000 | +166.4% | 0.07% | +165.4% |
| Q1 2022 | $1,137,000 | -81.8% | 1,170,000 | -82.3% | 0.03% | -93.3% |
| Q4 2020 | $6,232,000 | – | 6,623,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |